SYN2 p.Gly366Ser
c.1096G>A · rs369598543 · VCV2220412
Computational evidence
| Protein change | ||
| AlphaMissense | 0.3157 | likely benign |
|---|---|---|
| REVEL | 0.661 | pathogenic-leaning |
| SaProt | LLR -12.54 | damaging |
| ⇒ REVEL and SaProt call this damaging; AlphaMissense does not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 2.3, phastCons 1 |
| Regional constraint | o/e 1.02 | unconstrained · MANE · 186 kb · p 0.66 · regional, not allelic |
| Overall | ||
| CADD | 33.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.00223% | 44,882 |
| Finnishnot grpmax-eligible | 0.00156% | 64,016 |
| European (non-Finnish) | 0.000254% | 393,317 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- SYN2
- Protein
- p.Gly366Ser
- Coding
- c.1096G>A
- MANE Select
- NM_133625
- dbSNP
- rs369598543
- Type
- single nucleotide variant
- Location
- chr3:12168416 (GRCh38)
- Gene constraint
- LOEUF 0.539 · pLI 0.90 (gnomAD)
- Structure
- AlphaFold pLDDT 75.24
- Residue 366
- the 'c; actin-binding and synaptic-vesicle binding' region
Similar variants
- SYN2 p.Ala54Val Benign ★★ same type
- SYN2 p.Thr506Ala Benign ★★ same type
- SYN2 c.1369+21G>C Uncertain significance ★ same type
- SYN2 p.Ala302Gly Uncertain significance ★ same type
- SYN2 p.Ala546Gly Uncertain significance ★ ⚠ same type
- SYN2 p.Arg179Gln Uncertain significance ★ ⚠ same type
- SYN2 p.Arg186Gln Uncertain significance ★ ⚠ same type
- SYN2 p.Arg315Trp Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/syn2-p-gly366ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown